LINHULT MARTIN ET AL: "Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach." PROTEINS 1 MAY 2004, vol. 55, no. 2, 1 May 2004 (2004-05-01), pages 407-416, XP002488610 ISSN: 1097-0134 (B1)

ORLOVA ANNA ET AL: "Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors." CANCER RESEARCH 1 MAR 2007, vol. 67, no. 5, 1 March 2007 (2007-03-01), pages 2178-2186, XP002488607 ISSN: 0008-5472 cited in the application (B1)

ORLOVA ANNA ET AL: "Tumor imaging using a picomolar affinity HER2 binding affibody molecule." CANCER RESEARCH 15 APR 2006, vol. 66, no. 8, 15 April 2006 (2006-04-15), pages 4339-4348, XP002488605 ISSN: 0008-5472 (B1)

ORLOVA ANNA ET AL: "Update: affibody molecules for molecular imaging and therapy for cancer." CANCER BIOTHERAPY & RADIOPHARMACEUTICALS OCT 2007, vol. 22, no. 5, October 2007 (2007-10), pages 573-584, XP002488606 ISSN: 1084-9785 (B1)

WO-A-2007/065635 (B1)

TRAN THUY ET AL: "(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors." BIOCONJUGATE CHEMISTRY 2007 NOV-DEC, vol. 18, no. 6, November 2007 (2007-11), pages 1956-1964, XP002488608 ISSN: 1043-1802 (B1)

WIKMAN M ET AL: "Selection and characterization of HER2/neu-binding affibody ligands" PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, vol. 17, no. 5, 18 June 2004 (2004-06-18), pages 455-462, XP002982293 ISSN: 1741-0126 (B1)

WO-A-2005/003156 (B1)

TOLMACHEV VLADIMIR ET AL: "Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule." CANCER RESEARCH 15 MAR 2007, vol. 67, no. 6, 15 March 2007 (2007-03-15), pages 2773-2782, XP002488609 ISSN: 0008-5472 (B1)